- Lycium barbarum Polysaccharide Ameliorates Sjogren’s Syndrome in a Murine Model
- Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjogren’s syndrome
- Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib
- Effectiveness and Safety of Iguratimod in Treating Primary Sjogren’s Syndrome: A Systematic Review and Meta-Analysis
- Formation of Autoimmune Lesions Is Independent of Antibiotic Treatment in NOD Mice
- Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial” by de Wolff et al
- The Enduring Experience in Dry Eye Diagnosis: A Non-Interventional Study Comparing the Experiences of Patients Living With and Without Sjogren’s Syndrome
- Atypical Sjogren’s Syndrome Initially Presenting as Lymphocytic Interstitial Pneumonitis followed by Immune Thrombocytopenia
- Sjogren’s Syndrome and Pulmonary Disease
- Rabbit models of dry eye disease: Current understanding and unmet needs for translational research
- Mesenchymal stromal cells for the treatment of ocular autoimmune diseases
- Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjogren’s Syndrome-Associated Thrombocytopenia
- Glomerulonephritis with severe nephrotic syndrome induced by immune complexes composed of galactose-deficient IgA1 in primary Sjogren’s syndrome: a case report
- Coexistence of Sjogren syndrome in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A retrospective observational study
- Evaluation of Asymptomatic Bacteriuria and Urinary Tract Infection in Patients With Primary Sjogren’s Syndrome
- Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised controlled trial’
- Pathology of salivary gland dysfunction and restoration of function
- S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-alpha) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases
- Secreted factors from dental pulp stem cells improve Sjogren’s syndrome via regulatory T cell-mediated immunosuppression
- Muscle Tone Assessment under General Anesthesia for Sjogren-Larsson Syndrome and Spasticity
- Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system
- The relationship between Sjogren’s syndrome, systemic sclerosis and lymphoproliferative diseases
- Juvenile primary Sjogren’s syndrome with cutaneous involvement
- Salivary dysbiosis in Sjogren’s syndrome and a commensal-mediated immunomodulatory effect of salivary gland epithelial cells
- Reactivity of human labial glands in response to cevimeline treatment
- A Novel Approach for Immediate Implant-based Oral Rehabilitation in a Sjogren’s Syndrome Patient Using Virtual Surgical and Prosthetic Planning
- Sjogren’s syndrome: from diagnosis to treatment
- MTH1 inhibitors for the treatment of psoriasis
- Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjogren’s Syndrome Model Mice
- What is the evidence that mycobacteria are associated with the pathogenesis of Sjogren’s syndrome?
- Not all Sicca is Sjogren’s and not all Sjogren’s is Sicca
- Dental pulp-derived stem cell-conditioned media attenuates secondary Sjogren’s syndrome via suppression of inflammatory cytokines in the submandibular glands
- Severe pulmonary arterial hypertension and massive ascites in a patient with systemic lupus erythematosus and secondary Sjogren’s syndrome
- Deciphering potential pharmacological mechanism of Sha-Shen-Mai-Dong decoction on primary Sjogren’s syndrome
- Two shared immune cell signatures stratify patients with Sjogren’s syndrome and systemic lupus erythematosus with potential therapeutic implications
- Effects of cyclophosphamide and rituximab in patients with connective tissue diseases with severe interstitial lung disease
- Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
- Transduction of Salivary Gland Acinar Cells with a Novel AAV Vector 44.9
- The Impact of SARS-CoV-2 Outbreak on Primary Sjogren’s Syndrome: An Italian Experience
- Primary Sjogren’s syndrome manifesting as sclerotic metabolic bone disease
- Analysis of non-tuberculous mycobacterial lung disease in patients with primary Sjogren’s syndrome at a referral center
- Lymphocyte subpopulations in Sjogren’s syndrome are distinct in anti-SSA-positive patients and related to disease activity
- MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sjogren’s syndrome
- Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw
- Ocular Cicatricial Pemphigoid: Methotrexate as an Initial Treatment?
- Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy
- Immune Monitoring upon Treatment with Biologics in Sjogren’s Syndrome: The What, Where, When, and How
- Lacrimal gland atrophy and dry eye related to isotretinoin, androgen, and prolactin: differential diagnosis for Sjogren’s syndrome
- Neonatal lupus erythematosus – practical guidelines
- Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750
- New frontiers in precision medicine for Sjogren’s syndrome
- Interleukin 1alpha: a comprehensive review on the role of IL-1alpha in the pathogenesis and treatment of autoimmune and inflammatory diseases
- Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren’s syndrome versus non-Sjogren’s syndrome
- Systemic diseases and the cornea
- Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjogren’s Syndrome
- A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjogren Syndrome
- Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial” by Wang et al
- Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial’
- Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
- Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review
- Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
- Asymptomatic Lymphocytic Interstitial Pneumonia with Extensive HRCT Changes Preceding Sjogren’s Syndrome
- Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren’s syndrome: A review
- Normal salivary gland ultrasonography could rule out the diagnosis of Sjogren’s syndrome in anti-SSA-negative patients with sicca syndrome
- Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjogren’s syndrome (pSS) via suppressing NF-kappab signaling pathway
- Refractory IgG4-related Pleural Disease with Chylothorax: A Case Report and Literature Review
- Mild stimulatory effect of a probiotic mix on bone mass when treatment is initiated 1.5 weeks after ovariectomy in mice
- Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome
- CD8(+) T Lymphocytes: Crucial Players in Sjogren’s Syndrome
- Association between nucleos(t)ide analogue therapy for hepatitis B and Sjogren’s syndrome: 15-year analysis of the national database of Taiwan
- Role of the HSP70 Co-Chaperone SIL1 in Health and Disease
- Allogeneic and autologous serum eye drops: a pilot double-blind randomized crossover trial
- SS-A52 antigen expression in thymic carcinoma accompanied with Sjogren syndrome: A case report
- P2Y(2) receptor antagonism resolves sialadenitis and improves salivary flow in a Sjogren’s syndrome mouse model
- Correction to: Treatment of acute Achilles tendon rupture – a multicentre, non-inferiority analysis
- A Case of Immune-Mediated Necrotizing Myopathy Associated with Primary Sjogren Syndrome
- A case report of Mikulicz’s disease
- The Role of Interferons in the Pathogenesis of Sjogren’s Syndrome and Future Therapeutic Perspectives
- Ocular Cicatricial Pemphigoid, Sjogren’s Syndrome, and Hashimoto’s Thyroiditis as a Multiple Autoimmune Syndrome: A case report
- EULAR Sjögren’s syndrome study group: an eSSential way to address the unmet needs of the disease.
- Neonatal lupus presenting as a non-specific rash in primary care.
- Ocular Cicatricial Pemphigoid, Sjögren’s Syndrome, and Hashimoto’s Thyroiditis as a Multiple Autoimmune Syndrome: A case report.
- Differences in clinical features between small fiber and sensitive large fiber neuropathies in Sjögren’s syndrome.
- CD8+ T Lymphocytes: Crucial Players in Sjögren’s Syndrome.
- Primary Sjogren’s syndrome manifesting with distal renal tubular acidosis and severe metabolic bone disease.
- The Role of Interferons in the Pathogenesis of Sjögren’s Syndrome and Future Therapeutic Perspectives.
- Epidemiology of Non-Hodgkin’s Lymphoma.
- Neonatal lupus erythematosus presenting with rash, thrombocytopenia compounded by cytomegalovirus colonisation: a diagnostic dilemma.
- [A Case of Immune-Mediated Necrotizing Myopathy Associated with Primary Sjögren Syndrome].
- Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren’s syndrome patients: case series study and review of the literature.
- Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjögren’s syndrome.
- P2Y2 receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren’s syndrome mouse model.
- Association between nucleos(t)ide analogue therapy for hepatitis B and Sjögren’s syndrome: 15-year analysis of the national database of Taiwan.
- Vagus nerve stimulation in musculoskeletal diseases.
- Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases.
- Sicca syndrome following immune checkpoint inhibition.
- Hydroxychloroquine in systemic and auto-immune diseases: where are we now?
- Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren’s syndrome: A review.
- Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjögren’s syndrome (pSS) via suppressing NF-κb signaling pathway.
- Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications.
- Asymptomatic Lymphocytic Interstitial Pneumonia with Extensive HRCT Changes Preceding Sjogren’s Syndrome.
- Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren’s syndrome.
- Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial” by Wang et al.
- Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’.
- COVID-19 in Italian Sjögren’s syndrome patients: a monocentric study.
- Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjögren’s Syndrome.
- Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren’s syndrome versus non-Sjogren’s syndrome.
- Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750.
- A patient with primary Sjogren’s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review.
- Immune Monitoring upon Treatment with Biologics in Sjögren’s Syndrome: The What, Where, When, and How.
- Lacrimal gland atrophy and dry eye related to isotretinoin, androgen, and prolactin: differential diagnosis for Sjögren’s syndrome.
- Neonatal lupus erythematosus – practical guidelines.
- Mechanism of cAMP-PKA Signaling Pathway Mediated by Shaoyao Gancao Decoction () on Regulation of Aquaporin 5 and Muscarinic Receptor 3 Levels in Sjögren’s Syndrome.
- Clinical characteristics of systemic lupus erythematosus with chylothorax and/or chylous ascites: An analysis of 15 cases in China.
- Subacute cutaneous lupus erythematosus in a patient with Sjögren’s syndrome taking terbinafine for onychomycosis.
- Ocular Cicatricial Pemphigoid: Methotrexate as an Initial Treatment?
- Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?
- MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sjögren’s syndrome.
- Lymphocyte subpopulations in Sjögren’s syndrome are distinct in anti-SSA-positive patients and related to disease activity.
- Analysis of non-tuberculous mycobacterial lung disease in patients with primary Sjögren’s syndrome at a referral center.
- Primary Sjögren’s syndrome manifesting as sclerotic metabolic bone disease.
- The Impact of SARS-CoV-2 Outbreak on Primary Sjögren’s Syndrome: An Italian Experience.
- Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies.
- Suppression of high-mobility group box 1 ameliorates xerostomia in a Sjögren syndrome-triggered mouse model.
- Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome.
- [CAI Sheng-chao’s experience in treatment of Sjögren’s syndrome with moxibustion for promoting meridian circulation and warming yang].
- Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy.
- Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
- Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells.
- Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.
- Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren’s syndrome or systemic lupus erythematosus.
- Haematologic Indices And Disease Activity Index In Primary Sjogren’s Syndrome.
- [Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up].
- B7-H3: A promising therapeutic target for autoimmune diseases.
- Alleviating effect of paeoniflorin-6′-O-benzene sulfonate in antigen-induced experimental Sjögren’s syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK/p38 signaling pathway.
- High-Fat Diet-Induced Functional and Pathologic Changes in Lacrimal Gland.
- New developments in esophageal function testing and esophageal manifestations of connective tissue disorders.
- Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren’s Syndrome.
- Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
- Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment.
- Renal Disease in Primary Sjögren’s Syndrome.
- Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders.
- What’s new in ocular and oral aspects of Sjögren’s syndrome and do new treatments work?
- Association of salivary inflammatory biomarkers with primary Sjögren’s syndrome.
- Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.
- Transcranial Direct Current Stimulation for Fatigue in Patients with Sjogren’s Syndrome: a Randomized, Double-blind Pilot Study.
- Association Between Early Sjögren Markers and Symptoms and Signs of Dry Eye.
- Community-acquired Klebsiella pneumoniae central nervous system infection after acute suppurative otitis.
- Salivary Glands and Periodontal Changes in a Population of Sjögren’s and Sicca Syndrome Treated by Pilocarpine: A Pilot Study.
- Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development.
- Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjögren’s syndrome.
- The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus.
- Environmental factors in the pathogenesis of primary Sjögren’s syndrome.
- Proximal Muscle Weakness With Overlying Hypokalemic Periodic Paralysis in Sjögren Syndrome: Report of 6 Cases.
- Primary Sjögren’s Syndrome and Cardiovascular Disease.
- The impact of primary Sjogren’s syndrome on female sexual function.
- Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren’s Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.
- Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?
- Early diagnosis and treatment for Sjögren’s syndrome: current challenges, redefined disease stages and future prospects.
- Sjögren’s Syndrome Associated With Thrombotic Thrombocytopenic Purpura: A Case-Based Review.
- A Presentation of Pediatric Sjögren’s Syndrome with Abducens Nerve Palsy.
- [Primary diffuse large B-cell lymphoma of the breast in a male patient with Sjögren’s syndrome].
- Transduction of Salivary Gland Acinar Cells with a Novel AAV Vector 44.9.
- Idiopathic multicentric Castleman disease with Sjögren’s syndrome and secondary membranous nephropathy: a case report and review of the literature.
- Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome.
- Secretome Analysis of Inductive Signals for BM-MSC Transdifferentiation into Salivary Gland Progenitors.
- Clinical features and outcomes from the Singapore Sjögren’s syndrome study.
- Increased expression of interleukin-21-inducible genes in minor salivary glands are associated with primary Sjögren’s syndrome disease characteristics.
- Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy.
- Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia.
- Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.
- Sjögren’s syndrome with rapidly progressive motor neuron disease: a case report.
- The Prevalence of Sjögren’s Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features.
- Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren’s syndrome-associated dry eyes.
- Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
- Inhibition of bone morphogenetic protein 6 receptors ameliorates Sjögren’s syndrome in mice.
- Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases.
- Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report.
- [Renal involvement in Sjögren’s syndrome].
- Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.
- A Case of Prolonged Catatonia Caused by Sjögren’s Syndrome.
- Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis.
- Chemosensory dysfunction, Oral disorders and Oral health-related quality of life in patients with primary Sjögren’s syndrome: comparative cross-sectional study.
- Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial.
- Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically Based Pharmacokinetic Modeling.
- Successful Treatment of Urticarial Vasculitis in a Patient With Systemic Lupus Erythematosus With Rituximab.
- Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases.
- T Cells Subsets in the Immunopathology and Treatment of Sjogren’s Syndrome.
- Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases.
- Risk factors of attacks in neuromyelitis optica spectrum disorders.
- Tracheobronchial amyloidosis in primary Sjögren syndrome: A case report.
- Efficacy and safety of abatacept in active primary Sjögren’s syndrome: results of a phase III, randomised, placebo-controlled trial.
- [Dry mouth. Case histories from a saliva clinic].
- Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family.
- Unusual Presentation of Polyautoimmunity and Renal Tubular Acidosis in an Adolescent With Hashimoto’s Thyroiditis and Central Pontine Myelinolysis.
- Cytokines and Fatigue in Sjogren’s Syndrome: An Evolving Landscape.
- Office-based salivary gland ductal irrigation in patients with chronic sialoadenitis: A preliminary study.
- Sjögren syndrome associated with protein-losing enteropathy: case-based review.
- Burden of illness among subgroups of patients with primary Sjögren’s syndrome and systemic involvement.
- Catalpol ameliorates Sjögren’s Syndrome by modulating interplay of T and B cells.
- Sialendoscopy and Sjogren’s Disease: A Systematic Review.
- Neuromyelitis optica spectrum disorder complicated with Sjögren’s syndrome: first pediatric case responsive to mycophenolate mofetil treatment.
- Cardiovascular Protection of Hydroxychloroquine in Patients with Sjögren’s Syndrome.
- Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.
- Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren’s Syndrome.
- Variability of salivary metabolite levels in patients with Sjögren’s syndrome.
- Efficacy and safety of iguratimod on patients with primary Sjögren’s syndrome: a randomized, placebo-controlled clinical trial.
- Composite Epstein-Barr virus-positive mucosa-associated lymphoid tissue lymphoma and Epstein-Barr virus-negative diffuse large B-cell lymphoma in the parotid salivary gland of a patient with Sjögren’s syndrome and rheumatoid arthritis: a case report.
- Serious infections in Sjögren’s syndrome patients: a national U.S. study.
- Type-III interferons in Sjögren’s syndrome.
- A Training Tool to support the management and diagnosis of Sjögren’s syndrome.
- One year in review 2020: pathogenesis of primary Sjögren’s syndrome.
- Ianalumab (VAY736) in primary Sjögren’s syndrome: assessing disease activity using multi-modal ultrasound.
- Pathogenesis of primary Sjögren’s syndrome beyond B lymphocytes.
- Mediterranean diet and risk of Sjögren’s syndrome.
- Biologic therapy in Sjögren’s syndrome.
- Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in transbronchial lung cryobiopsy.
- A Fast and Clean BTK Inhibitor.
- Treatment of primary sjögren’s syndrome-related interstitial lung disease: a retrospective cohort study.
- Clinically significant renal involvement in primary Sjögren’s syndrome is associated with important morbidity: data from the Spanish Sjögrenser cohort.
- What about glucocorticoids in primary Sjögren’s syndrome?
- Interstitial lung disease in Sjögren’s syndrome: a clinical review.
- Blocking T cell co-stimulation in primary Sjögren’s syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers.
- Primary Sjögren’s syndrome: central and peripheral nervous system involvements.
- Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren’s Syndrome.
- A case report, a case who developed limited cutaneous scleroderma and pulmonary hypertension 8 years after diagnosis of anti-centromere antibody-positive Sjögren syndrome.
- Distal Renal Tubular Acidosis in Sjögren’s Syndrome: A Case Report.
- Fitness for purpose of routinely recorded health data to identify patients with complex diseases: The case of Sjögren’s syndrome.
- Reduced salivary flow and caries status are correlated with disease activity and severity in patients with diffuse cutaneous systemic sclerosis.
- Artesunate inhibits Sjögren’s syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
- Pulmonary Manifestations of Primary Sjögren’s Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.
- Small trial with short duration does not provide evidence that probiotics reduce the risk of developing oral candidiasis in patients with Sjögren syndrome.
- Development and exacerbation of pulmonary nontuberculous mycobacterial infection in patients with systemic autoimmune rheumatic diseases.
- Interleukin-7/Interferon axis drives T-cell and salivary gland epithelial cell interactions in Sjögren’s syndrome.
- Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren’s model.
- Mycophenolate for the Treatment of Primary Sjögren’s Syndrome.
- B7-H4 Inhibits the Development of Primary Sjögren’s Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
- Takotsubo syndrome and rheumatic diseases-a critical systematic review.
- Cytokine profiles and clinical characteristics in primary Sjögren´s syndrome patient groups.
- Pilocarpine for Sjögren’s Syndrome-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
- Pilocarpine for Radiotherapy-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
- Clinical profile and associated factors of pulmonary involvement in primary Sjögren’s syndrome.
- [Analysis of clinical features and prognosis in patients with primary Sjögren’s syndrome and autoimmune liver disease].
- [Nasal manifestations of Sjogren’s syndrome].
- Biomarkers and Diagnostic Testing for Renal Disease in Sjogren’s Syndrome.
- Stem cell treatments for oropharyngeal dysphagia: Rationale, benefits, and challenges.
- Checkpoint inhibition-induced sicca: a type II interferonopathy?
- Comorbidity and health care utilisation in persons with Sjögren’s syndrome: a claims data analysis.
- Compromised ultrasound remission, functional ability and clinical decision associated with overlapping Sjögren’s syndrome in rheumatoid arthritis patients: results from a propensity-score matched cohort from 2009 to 2019.
- Characterisation of articular manifestations in primary Sjögren’s syndrome: clinical and imaging features.
- T cell lymphoma in the setting of Sjögren’s syndrome: T cells gone bad? Report of five cases from a single centre cohort.
- Primary Sjögren’s Syndrome Accompanied by Clinical Features of TAFRO Syndrome.
- Comparison of Rituximab Originator With CT-P10 Biosimilar in Patients With Primary Sjögren’s Syndrome: A Retrospective Analysis in a Real-Life Setting.
- sPLA2-IIa participates in ocular surface inflammation in humans with dry eye disease.
- [Immune disorders associated with juvenile recurrent chronic parotitis].
- Clinical phenotyping of primary Sjögren’s patients using salivary gland ultrasonography – data from the RESULT cohort.
- Innate immune response in systemic autoimmune diseases: a potential target of therapy.
- Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study.
- Biologics in the treatment of Sjogren’s syndrome, systemic lupus erythematosus, and lupus nephritis.
- Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
- Myasthenia Gravis Coexisting With Primary Sjögren’s Syndrome: Report of Three Cases and Literature Review.
- Bipolar Disorder as Comorbidity with Sjögren’s Syndrome: What Can We Do?
- Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
- Recurrent breast amyloidosis associated with Sjögren’s syndrome: A case report with description of the radiologic-pathologic correlation.
- Diffuse Cystic Lung Disease: Consider Sjögren Syndrome in the Differential Diagnosis.
- Autoimmune Myelofibrosis in Sjögren’s Syndrome: Report of a Case.
- A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome.
- Utility of the EULAR Sjögren syndrome disease activity index in Japanese children: a retrospective multicenter cohort study.
- [Inflammation in Dry Eye Disease – Information on Diagnostic Testing and Therapy Using the Scientific Online Information Platform OSCB-Berlin.org].
- LAMP3 induces apoptosis and autoantigen release in Sjögren’s syndrome patients.
- One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren’s syndrome.
- Evaluation of soluble CD25 as a clinical and autoimmune biomarker in primary Sjögren’s syndrome.
- An objective method of diagnosing hydroxychloroquine maculopathy.
- Kikuchi-Fujimoto disease associated with primary Sjögren’s syndrome – literature review based on a case report.
- Mesenchymal stem cell transplantation alleviates experimental Sjögren’s syndrome through IFN-β/IL-27 signaling axis.
- Hypokalemic paralysis as an initial presentation of Sjogren syndrome.
- Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD
- The BAFF / APRIL system as therapeutic target in multiple sclerosis.
- Recent Advances in the Use of Exosomes in Sjögren’s Syndrome.
- Study of Safety and Tolerability of CFZ533 in Patients With Sjögren’s Syndrome
- A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
- Molecular Targeting of Immunosuppressants Using a Bifunctional Elastin-Like Polypeptide.
- The effect of pilocarpine on dental caries in patients with primary Sjögren’s syndrome: a database prospective cohort study.
- Clinical practice guidance for Sjögren’s syndrome in pediatric patients (2018) – summarized and updated.
- Immune checkpoint inhibitors-induced autoimmunity: The impact of gender.
- Transverse myelitis associated with primary biliary cirrhosis: clinical, laboratory, and neuroradiological features.
- Infections in systemic autoimmune diseases.
- The challenge of managing comorbidities: a case report of primary Sjogren’s syndrome in a patient with acute intermittent porphyria.
- Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending.
- Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors.
- Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
- Prognostic factors for primary Sjögren’s syndrome-associated interstitial lung diseases.
- Characterization of a subset of patients with primary Sjögren’s syndrome initially presenting with C3 or C4 hypocomplementemia.
- Connective tissue disease–associated interstitial lung disease: an underreported cause of interstitial lung disease in Sub-Saharan Africa.
- Dental Implants in Sjögren Syndrome.
- Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment.
- Refining myositis associated with primary Sjögren’s syndrome: data from the prospective cohort ASSESS.
- Cricoarytenoid joint arthritis: a possible complication of dermatomyositis.
- [Local and systemic light chain amyloidosis in patients with rheumatic diseases].
- Acute severe sensory ganglionopathy in systemic lupus erythematous.
- Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
- Uveal Effusion Syndrome as the Initial Manifestation of Primary Sjögren’s Syndrome and Review of the Literature.
- Nodular localized primary cutaneous amyloidosis and primary Sjögren’s syndrome.
- The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK.
- [New directions of pharmacotherapy of immune – inflammatory rheumatic diseases].
- An Innovative Online Qualitative Study to Explore the Symptom Experience of Patients with Primary Sjögren’s Syndrome.
- Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies.
- Hydroxychloroquine in rheumatic autoimmune disorders and beyond.
- Corneal In Vivo Laser-Scanning Confocal Microscopy Findings in Dry Eye Patients with Sjögren’s Syndrome.
- Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases Part 2.
- A Complex Case of Polymyositis Overlapping With Hypothyroid Myopathy Without Underlying Autoimmune Thyroid Disorder.
- Axial articular manifestations in primary Sjögren’s syndrome: Association with spondyloarthritis.
- Multiple sclerosis and neuromyelitis optica after optic neuritis: A nationwide cohort study in Taiwan.
- Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis.
- Lymphangioleiomyomatosis: A Case Report and Review of Clinical Features and Management.
- Concomitant Sjögren’s Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis.
- Pulmonary Involvement in a Mouse Model of Sjögren’s Syndrome Induced by STING Activation.
- Focus on Effects of Chinese Medicine on Improving Anxiety-Depression and Quality of Life of Patients with Primary Sjögren’s Syndrome.
- Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies.
- Concurrent primary Sjögren’s syndrome and isolated ocular sarcoidosis presenting with bilateral corneal scarring and dry eye.
- Characteristics of primary Sjögren’s syndrome related lymphocytic interstitial pneumonia.
- The multifaceted functional role of DNA methylation in immune-mediated rheumatic diseases.
- [Sjögren’s syndrome with juvenile onset].
- A Case of Sjögren’s Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer.
- Spontaneous pregnancies in patients with at least one failed IVF cycle after the management of autoimmune disorders, hereditary thrombophilia, and methylation disorders.
- Coexistence of Sarcoidosis and Sjögren’s syndrome with hypercalcemia and renal involvement: A case report and literature review.
- Complicated case of Mycobacterium abscessus conjunctivitis in Sjögren’s syndrome.
- A Tutorial on Saliva’s Role in Swallowing With a Focus on Sjögren’s Syndrome.
- Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease
- Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren’s Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors.
- Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature.
- Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren’s syndrome enrolled in a large observational US registry.
- The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases
- Peritoneal Carcinomatosis in an Adult With Sjögren’s Syndrome: A Diagnostic Dilemma Revealing a Rare Association With Primary Gastric Adenocarcinoma.
- Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone.
- Tirabrutinib: First Approval.
- Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action.
- Effectiveness of resistance exercise in functional fitness in women with primary Sjögren’s syndrome: randomized clinical trial.
- Syndrome de Sjögren.
- Hospital admission for blood collection for the preparation of autologous serum eye drops.
- Congenital Complete Atrioventricular Heart Block in a Pregnant Woman with Sjögren Syndrome: Prenatal Care Follow-Up and the Challenge of Intrauterine Treatment.
- Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy: A Case Report.
- [Mesenchymal stem cell treatment in autoimmune diseases].
- Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjögren’s syndrome.
- Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor.
- Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjögren’s Syndrome Dry Eye.
- Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection.
- Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
- Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren’s syndrome mouse model.
- New Viral Facets in Oral Diseases: The EBV Paradox.
- Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy.
- Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy.
- Achaete-Scute Homologue 2-Regulated Follicular Helper T Cells Promote Autoimmunity in a Murine Model for Sjögren Syndrome.
- [Primary Sjögren’s Syndrome – News on Diagnostics and Therapy].
- P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction.
- Complementary therapy with traditional Chinese medicine for a patient with Sjögren’s syndrome: A case report.
- Pulmonary Involvement in Sjögren Syndrome.
- [The necessity and importance of standardized diagnosis and treatment of primary Sjögren’s syndrome].
- [Recommendations of diagnosis and treatment of primary Sjögren’s syndrome in China].
- Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome
- Effects of Acupuncture on Sjögren’s Syndrome
- Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
- Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sjögren’s syndrome reveals a pathogenic signature.
- Shear wave elastography as a new method to identify parotid lymphoma in primary Sjögren Syndrome patients: an observational study.
- Colchicine as possible treatment of non-cryoglobulinaemic vasculitis in Sjögren’s syndrome.
- Dual function of miR-1248 links interferon induction and calcium signaling defects in Sjögren’s syndrome.
- RESET Trial – Part 1 (Followed by Reset Trial – Part 2) – A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)
- Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren’s syndrome.
- Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy.
- Recurrent aseptic meningitis: A rare clinical presentation of Sjogren’s syndrome.
- Hyperkalemia in type 4 renal tubular acidosis associated with systemic lupus erythematosus.
- [Targeted therapies for connective tissue diseases and vasculitis].
- Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.
- Somatosensory profile of a patient with mixed connective tissue disease and Sjögren syndrome.
- Severe anemia caused by hereditary hemorrhagic telangiectasia in a patient with Sjögren’s syndrome and primary biliary cirrhosis.
- Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sjögren syndrome.
- HTLV-1 Infection and Rheumatic Diseases.
- Stratifying Sjögren syndrome into symptom-based subgroups.
- Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren’s syndrome.
- Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren’s syndrome to facilitate their concerted migration.
- Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
- Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren’s syndrome.
- Intravenous immunoglobulin efficacy for primary Sjögren’s Syndrome associated small fiber neuropathy.
- Characteristics and risk factors for pulmonary arterial hypertension associated with primary Sjögren’s syndrome: 15 new cases from a single center.
- Association of Sjögren’s syndrome with myotonic dystrophy type 1.
- Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice.
- The Traditional Chinese Medicine Fufang Shatai Heji (STHJ) Enhances Immune Function in Cyclophosphamide-Treated Mice.
- Sjögren’s Syndrome with Cerebral Venous Sinus Thrombosis: A Case Report and Literature Review.
- Adolescent Sjogren’s syndrome presenting as psychosis: a case series.
- Efficacy of dupilumab reveals therapeutic target for IgG4-related disease: simultaneous control of inflammation and fibrosis.
- [Primary thymic mucosa-associated lymphoid tissue lymphoma: 7 clinical cases report and a review of the literature].
- Antifibrotics in interstitial lung disease related to connective tissue diseases – a paradigm shift in treatment and outcome.
- the Effect of Mixture of Natural Products As Salivary Substitutes in Treatment Of Xerostomia
- Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjögren’s syndrome.
- Toward better outcomes in Sjögren’s syndrome: The promise of a stratified medicine approach.
- Emergence of rheumatoid arthritis following exposure to natalizumab.
- Pulmozyme for Sjogren’s Associated Cough
- Levocarnitine for Dry Eye in Sjogren’s Syndrome
- A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome
- Tolerance and Efficiency of an Intrabuccal Biological Film to Enhance Oral Dryness Sensation: The “PREDELFI” Clinical Pilot Study
- Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren’s Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
- Hyperglycemia and Salivary Gland Dysfunction in the Non-obese Diabetic Mouse: Caveats for Preclinical Studies in Sjögren’s Syndrome.
- Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye
- Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome.
- Overactive bladder and bladder pain syndrome/interstitial cystitis in primary Sjögren’s syndrome patients: A nationwide population-based study.
- Sweet’s Syndrome Following Therapy with Hydroxychloroquine in a Patient Affected with Elderly-Onset Primary Sjogren’s Syndrome.
- A 45-Year-Old Woman With Multiple Pulmonary Nodules and Sjögren Syndrome.
- Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis.
- Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
- The value of MiR-146a and MiR-4484 expressions in the diagnosis of anti-SSA antibody positive Sjogren syndrome and the correlations with prognosis.
- Prognostic factors for primary Sjögren’s syndrome-associated interstitial lung diseases.
- Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases
- Omalizumab for Lupus
- Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren’s Syndrome
- Secondary Sjögren syndrome: A case report using silver diamine fluoride and glass ionomer cement.
- Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS).
- Increased risk of aortic aneurysm and dissection in patients with Sjögren’s syndrome: a nationwide population-based cohort study in Taiwan.
- Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease
- Associations between Antibiotics for Non-tuberculous Mycobacterial Infection and Incident Sjögren’s Syndrome: A Nationwide, Population-based Case-control Study.
- Nivolumab in Treating Patients With Autoimmune Disorders or Advanced, Metastatic, or Unresectable Cancer
- A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts